Tranexamic acid for trauma-related hemorrhage

Area of Science:

• Trauma and Emergency Medicine
• Pharmacology
• Hemorrhage Control

Background:

• Trauma-related deaths are a leading cause of mortality in individuals under 45.
• Hemorrhage is a significant factor in trauma mortality, disrupting hemostasis.
• Current resuscitation strategies involve surgery, volume restoration, and pharmacologic agents.

Purpose of the Study:

• To review the role of tranexamic acid in managing trauma-related hemorrhage.
• To highlight its mechanism of action and proven efficacy in reducing mortality.
• To discuss its expanding applications in trauma care.

Main Methods:

• Review of prospective studies on tranexamic acid in trauma.
• Analysis of its antifibrinolytic mechanism.
• Discussion of its integration into resuscitation and massive transfusion protocols.

Main Results:

• Tranexamic acid is an antifibrinolytic agent that inhibits fibrinolysis.
• It stabilizes existing clots, preventing their degradation.
• Prospective studies demonstrate a reduction in mortality from trauma-related hemorrhage with its use.

Conclusions:

• Tranexamic acid is a critical pharmacologic intervention for trauma-induced hemorrhage.
• Its use is expanding into resuscitation, massive transfusion protocols, and prehospital settings.
• Emergency medicine providers must be knowledgeable about its appropriate use to optimize outcomes and minimize adverse events.